Analysis of the treatment costs of HIV/AIDS in Turkey


Kockaya G., Zengin T. E. , Yenilmez F. B. , Dalgic C., Malhan S., Cerci P., ...Daha Fazla

FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, cilt.17, sa.1, ss.13-17, 2016 (ESCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 17 Konu: 1
  • Basım Tarihi: 2016
  • Doi Numarası: 10.7175/fe.v17i1.1219
  • Dergi Adı: FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS
  • Sayfa Sayıları: ss.13-17

Özet

OBJECTIVE: Infection with the human immunodeficiency virus (HIV), the causative agent of acquired immune deficiency syndrome (AIDS), is a major global health problem. Patients with HIV can live normal lives with today's new treatment options. As the treatment is generally successful, the life expectancy of patients infected with HIV is rising. As a result, the economic burden of HIV treatment on health systems is set to increase. According to the Ministry of Health, there were more than 6000 HIV-positive patients in Turkey in 2013. The aim of this study was to determine the direct costs of HIV treatment in Turkey.